MX2020008969A - Tratamiento y prevencion de preeclampsia. - Google Patents

Tratamiento y prevencion de preeclampsia.

Info

Publication number
MX2020008969A
MX2020008969A MX2020008969A MX2020008969A MX2020008969A MX 2020008969 A MX2020008969 A MX 2020008969A MX 2020008969 A MX2020008969 A MX 2020008969A MX 2020008969 A MX2020008969 A MX 2020008969A MX 2020008969 A MX2020008969 A MX 2020008969A
Authority
MX
Mexico
Prior art keywords
eclampsia
prevention
treatment
medicine
specifically
Prior art date
Application number
MX2020008969A
Other languages
English (en)
Inventor
Vries Sijmen De
Bruno Giannetti
Original Assignee
Pharming Intellectual Property B V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharming Intellectual Property B V filed Critical Pharming Intellectual Property B V
Publication of MX2020008969A publication Critical patent/MX2020008969A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Abstract

La presente invención se refiere al campo de la medicina y en particular para la prevención y tratamiento de la preeclampsia.
MX2020008969A 2018-02-28 2019-02-28 Tratamiento y prevencion de preeclampsia. MX2020008969A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP18159064 2018-02-28
PCT/EP2019/055001 WO2019166556A1 (en) 2018-02-28 2019-02-28 Treatment and prevention of pre-eclampsia

Publications (1)

Publication Number Publication Date
MX2020008969A true MX2020008969A (es) 2021-02-16

Family

ID=61521416

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2020008969A MX2020008969A (es) 2018-02-28 2019-02-28 Tratamiento y prevencion de preeclampsia.

Country Status (15)

Country Link
US (1) US20200390872A1 (es)
EP (1) EP3758739B1 (es)
JP (1) JP2021515757A (es)
KR (1) KR20210005549A (es)
CN (1) CN111818938A (es)
AU (1) AU2019226355A1 (es)
BR (1) BR112020017626A2 (es)
CA (1) CA3092163A1 (es)
EA (1) EA202092045A1 (es)
IL (1) IL276905A (es)
MA (1) MA52121A (es)
MX (1) MX2020008969A (es)
PH (1) PH12020551331A1 (es)
SG (1) SG11202008078QA (es)
WO (1) WO2019166556A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3895726A1 (en) 2020-04-17 2021-10-20 Pharming Intellectual Property BV Using c1 esterase inhibitor to treat viral infection-related acute respiratory distress
WO2023280981A1 (en) 2021-07-09 2023-01-12 Pharming Intellectual Property B.V. Using c1 esterase inhibitor to treat viral infection-related symptoms

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992022320A1 (en) * 1991-06-14 1992-12-23 Genentech, Inc. C1 inhibitor variants and treating inflammatory response with c1 inhibitor
GB9618931D0 (en) 1996-09-11 1996-10-23 Univ London Inositol phosphoglycans for therapeutic use in pre-eclampsia and diabetes
US7067713B2 (en) * 2000-01-31 2006-06-27 Pharming Intellectual Property B.V. C1 Inhibitor produced in the milk of transgenic non-human mammals
WO2001057079A2 (en) 2000-01-31 2001-08-09 Pharming Intellectual Property B.V. C1 inhibitor produced in the milk of transgenic mammals
US20050255114A1 (en) * 2003-04-07 2005-11-17 Nuvelo, Inc. Methods and diagnosis for the treatment of preeclampsia
US7544853B2 (en) * 2003-05-16 2009-06-09 Pharming Intellectual Property B.V. C1 inhibitor with short half-life transient treatment
AU2006327989B2 (en) 2005-12-21 2012-06-07 Pharming Intellectual Property Bv Use of C1 inhibitor for the prevention of ischemia-reperfusion injury
CN105641688B (zh) * 2005-12-21 2020-06-09 法明知识产权股份有限公司 C1抑制剂在预防缺血-再灌注损伤中的应用
WO2014066744A2 (en) * 2012-10-25 2014-05-01 True North Therapeutics, Inc. Anti-complement c1s antibodies and uses thereof
US20150330989A1 (en) * 2012-11-15 2015-11-19 The Brigham And Women's Hospital, Inc. Method and system for diagnosing and treating preeclampsia
PL3290046T3 (pl) 2013-03-15 2019-05-31 Shire Viropharma Inc Kompozycje c1-inh i sposoby do zapobiegania i leczenia zaburzeń związanych z niedoborem inhibitora c1 esterazy
WO2016081889A1 (en) * 2014-11-21 2016-05-26 Kurt Baekgaard Osther Recombinant c1 esterase inhibitor and use thereof
MA45473A (fr) 2016-04-04 2019-02-13 Shire Human Genetic Therapies Inhibiteur de c1 estérase conjugué et ses utilisations
EP3895726A1 (en) * 2020-04-17 2021-10-20 Pharming Intellectual Property BV Using c1 esterase inhibitor to treat viral infection-related acute respiratory distress

Also Published As

Publication number Publication date
KR20210005549A (ko) 2021-01-14
EP3758739A1 (en) 2021-01-06
WO2019166556A1 (en) 2019-09-06
CN111818938A (zh) 2020-10-23
PH12020551331A1 (en) 2021-09-06
EP3758739B1 (en) 2024-05-15
AU2019226355A1 (en) 2020-09-17
BR112020017626A2 (pt) 2020-12-22
US20200390872A1 (en) 2020-12-17
JP2021515757A (ja) 2021-06-24
SG11202008078QA (en) 2020-09-29
MA52121A (fr) 2021-06-02
CA3092163A1 (en) 2019-09-06
EA202092045A1 (ru) 2020-11-09
IL276905A (en) 2020-10-29

Similar Documents

Publication Publication Date Title
EA201891200A1 (ru) Композиции, содержащие бактериальные штаммы
MX2023003461A (es) Tratamiento de infeccion por clostridium difficile.
EA201891199A1 (ru) Композиции, содержащие бактериальные штаммы
EA201890048A1 (ru) Композиции, содержащие бактериальные штаммы
EA201890047A1 (ru) Композиции, содержащие бактериальные штаммы
EA201890051A1 (ru) Композиции, содержащие бактериальные штаммы
EA201891202A1 (ru) Композиции, содержащие бактериальные штаммы
EA201891201A1 (ru) Композиции, содержащие бактериальные штаммы
GEP20247593B (en) Compositions and methods of inhibiting masp-3 for the treatment of various diseases and disorders
EA201890050A1 (ru) Композиции, содержащие бактериальные штаммы
EA201890049A1 (ru) Композиции, содержащие бактериальные штаммы
MX2020013468A (es) Anticuerpos il-11ra.
MX2018008105A (es) Compuestos inhibidores de metaloenzima.
MX2020005567A (es) Metodos de tratamiento con asparaginasa.
MX2018009325A (es) Compuestos y metodos para tratar enfermedades mediadas por el acido ribonucleico (arn).
MX2018005233A (es) Combinacion de inhibidor de bcl-2 e inhibidor de mek para el tratamiento de cancer.
PH12018501279A1 (en) Compositions comprising 15-hepe and methods of using the same
MX2020003219A (es) Anticuerpos que tienen especificidad para btn2 y usos de los mismos.
MX2017014456A (es) Usos terapeuticos de l-4-cloroquinurenina.
PH12018502318A1 (en) Compositions and methods for treatment of inflammation of infection of the eye
PH12020551331A1 (en) Treatment and prevention of pre-eclampsia
ZA202105101B (en) Peptides for treatment and prevention of diabetes and associated disorders
MX2020001632A (es) Composiciones que comprenden cepas bacterianas.
WO2020109233A3 (en) Trmt2a inhibitors for use in the treatment of polyglutamine diseases
PH12019502915A1 (en) Immunogenic compositions